FrancophonIA/ELRC3.0 huggingface dataset:
English: Following weekly administration of 2 mg Bydureon BCise, mean exenatide concentrations exceeded minimal efficacious concentrations (~ 50 pg/ml) in 2 weeks with gradual increase in the average plasma exenatide concentration up to Week 8.
Slovenian: Ob tedenskem dajanju 2 mg zdravila Bydureon BCise je povprečna koncentracija eksenatida v dveh tednih presegla minimalno učinkovito koncentracijo (~ 50 pg/ml), s postopnim povečevanjem povprečne plazemske koncentracije eksenatida do 8. tedna.
English: Other medicines and Bydureon Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, particularly: - other medicines that are used to treat type 2 diabetes, such as medicines that work like Bydureon (for example: liraglutide or other exenatide containing products, as taking these medicines with Bydureon is not recommended.
Slovenian: Druga zdravila in zdravilo Bydureon Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo, še zlasti: - druga zdravila za zdravljenje sladkorne bolezni tipa 2, na primer zdravila, ki delujejo podobno kot zdravilo Bydureon (npr. liraglutid ali druga zdravila, ki vsebujejo eksenatid), ker uporaba teh zdravil skupaj z zdravilom Bydureon ni priporočljiva.
English: When prolonged-release exenatide is used in combination with a sulphonylurea, patients should be advised to take precautions to avoid hypoglycaemia while driving and using machines.
Slovenian: Kadar eksenatid v obliki s podaljšanim sproščanjem uporabljamo v kombinaciji s sulfonilsečnino, moramo bolnikom svetovati o previdnostnih ukrepih, da bi se med vožnjo in upravljanjem strojev izognili hipoglikemiji.
English: Hold the pen up to the light and look through both sides of the mixing window.
Slovenian: Peresnik držite pokonci proti svetlobi in poglejte skozi obe strani okenca za mešanje.
English: You should inject this medicine immediately after mixing the suspension.
Slovenian: To zdravilo si morate po mešanju suspenzije takoj injicirati.
English: However, after you unlock it, you must complete the preparation steps right away and inject to get the full dose.
Slovenian: Toda ko ga odklenete, morate takoj opraviti korake za pripravo in zdravilo injicirati, da boste dobili celoten odmerek.
English: Mixed Well
Slovenian: Dobro premešano
English: Approximately 49.3% had mild renal impairment (estimated glomerular filtration rate [eGFR] ≥60 to ≤89 mL/min/1.73 m2) and 21.6% had moderate renal impairment (eGFR
Slovenian: Približno 49,3 % bolnikov je imelo blago okvaro ledvic (ocenjena hitrost glomerularne filtracije [eGFR] ≥ 60 do ≤ 89 ml/min/1,73 m2) in 21,6 % jih je imelo zmerno okvaro ledvic (eGFR ≥ 30 do ≤ 59 ml/min/1,73 m2).
English: Small subcutaneous injection site nodules were observed very frequently in clinical studies, consistent with the known properties of poly (D,L-lactide co-glycolide) polymer microsphere formulations.
Slovenian: V kliničnih študijah so se na mestu injiciranja zelo pogosto pojavili majhni podkožni noduli, kar je skladno z znanimi lastnostmi poli (D,L-laktid koglikolid) polimernih mikrosfernih formulacij.
English: Treatment with prolonged-release exenatide persistently significantly improved glycaemic control and weight control, compared to the insulin glargine treatment.
Slovenian: Zdravljenje z eksenatidom v obliki s podaljšanim sproščanjem je trajno izboljšalo urejenost glikemije in nadzorovanje telesne mase, v primerjavi z zdravljenjem z insulinom glarginom.
English: The two chambers are separated by a second chlorobutyl rubber piston.
Slovenian: Prekata med seboj loči drugi bat iz klorobutilne gume.
English: Event Rate n (%)
Slovenian: Delež dogodkov n (%)
English: Use a puncture-resistant container to throw away the pen with the needle still attached.
Slovenian: Uporabite vsebnik, odporen proti prebadanju, da boste zavrgli peresnik, na katerem je še vedno nameščena igla.
English: Follow the “Instructions for the User” provided in the carton to inject Bydureon BCise
Slovenian: Sledite “Navodilom za uporabnika”, ki se nahajajo v škatli, za injiciranje zdravila Bydureon BCise.
English: Includes acute renal failure, worsened chronic renal failure, renal impairment, increased serum creatinine.
Slovenian: Vključuje akutno odpoved ledvic, poslabšanje kronične odpovedi ledvic, okvaro ledvic, zvišanje kreatinina v serumu.
English: • The pen must be stored flat.
Slovenian: • Peresnik je treba shranjevati v vodoravnem položaju.
English: If not mixed well, continue to shake hard.
Slovenian: Če zdravilo ni dobro premešano, ga še naprej močno pretresajte.
English: Thyroid tumours have been observed in rats and mice with long acting GLP-1 receptor agonists.
Slovenian: Pri podganah in miših so ob dolgodelujočih agonistih receptorjev GLP-1 opažali tumorje ščitnice.
English: Slowly push in the plunger so the top of the plunger lines up with the black dashed Dose Line.
Slovenian: Počasi pritisnite bat tako, da bo vrh bata poravnan s črno odmerno črto.
English: Administration of exenatide has been shown to reduce food intake, due to decreased appetite and increased satiety.
Slovenian: Ugotovili so, da uporaba eksenatida zaradi zmanjšanega apetita in povečanega občutka sitosti zmanjša vnos hrane.
English: Hepatic impairment No dose adjustment is necessary for patients with hepatic impairment (see section 5.2).
Slovenian: Okvara jeter Pri bolnikih z okvaro jeter odmerka ni potrebno prilagajati (glejte poglavje 5.2).
English: At the study endpoint, approximately 43% of patients had low titre antibodies to exenatide and 14% of patients had high titre antibodies.
Slovenian: Ob koncu študije je imelo nizke titre protiteles proti eksenatidu približno 43 % bolnikov in visoke titre 14 % bolnikov.
English: In a single-dose pharmacokinetic study of immediate-release exenatide in 13 patients with type 2 diabetes and between the ages of 12 and 16 years, administration of exenatide (5 mcg) resulted in slightly lower mean AUC (16% lower) and Cmax (25% lower) compared to those observed in adults.
Slovenian: V farmakokinetični študiji z eksenatidom v obliki s takojšnim sproščanjem pri 13 bolnikih z diabetesom tipa 2, starih med 12 in 16 let, je dajanje eksenatida (5 g) rahlo znižalo povprečno vrednost AUC (16 % nižja) in Cmax (25 % nižja) v primerjavi z vrednostmi, ki so jih opazili pri odraslih.
English: One needle is a spare.
Slovenian: Ena igla je dodatna.
English: There is a spare needle in case you need it.
Slovenian: Imate tudi dodatno iglo, v kolikor bi jo potrebovali.
English: You can inject each dose of the medicine in your stomach area (abdomen), your thigh, or the back of your upper arm.
Slovenian: Vsak odmerek si lahko injicirate v področje trebuha (abdomna), stegna ali zadnjega dela nadlakti.
English: Insulin glargine was dosed targeting a fasting plasma glucose of 4.0 to 5.5 mmol/l (72 to 99 mg/dl).
Slovenian: Odmerek insulina glargina je bil določen s ciljno koncentracijo glukoze v plazmi na tešče od 4,0 do 5,5 mmol/l (72 do 99 mg/dl).
English: The solution should have NO CLUMPS and be uniformly cloudy.
Slovenian: V raztopini NE SME BITI GRUDIC in biti mora enakomerno motna.
English: Review the Instructions for the User Step 3 to confirm the order of operations, then contact the local representative of the Marketing Authorisation Holder (see section 6 of the Package Leaflet for a list of contacts by country).
Slovenian: Ponovno preglejte 3. korak v navodilih za uporabnika, da boste preverili zaporedje operacij, nato se obrnite na lokalnega predstavnika imetnika dovoljenja za promet z zdravilom (glejte poglavje 6 v navodilu za uporabo za seznam kontaktnih podatkov po državah).
English: A study of 26-week duration has been conducted, in which prolonged-release exenatide 2 mg is compared to insulin glargine once daily.
Slovenian: V 26-tedenski študiji so primerjali 2 mg eksenatida v obliki s podaljšanim sproščanjem z insulinom glarginom enkrat dnevno.
English: Warnings and precautions Talk to your doctor, pharmacist, or diabetes nurse before using Bydureon about the following: - If you use this medicine in combination with a sulphonylurea, as low blood sugar (hypoglycaemia) can occur.
Slovenian: Opozorila in previdnostni ukrepi Pred začetkom uporabe zdravila Bydureon se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro v diabetološki ambulanti o naslednjem: - Če uporabljate to zdravilo v kombinaciji s sulfonilsečnino, ker lahko pride do nizkega sladkorja v krvi (hipoglikemije).
English: Where to learn more about Bydureon
Slovenian: Kje se lahko izve več o zdravilu Bydureon
English: This is to make sure you get the full dose.
Slovenian: Tako boste zagotovili, da boste dobili celoten odmerek.
English: - The other ingredients are: poly (D,L-lactide-co-glycolide), sucrose and medium chain triglyceride.
Slovenian: - Druge sestavine zdravila so: poli (D,L-laktid koglikolid), saharoza in srednjeverižni triglicerid.
English: For prolonged-release exenatide treated patients, the incidence of potentially immunogenic injection site reactions (most commonly pruritus with or without erythema) during the 30-week and the two 26-week studies was 9%.
Slovenian: Incidenca možno imunogenih reakcij na mestu injiciranja (najpogosteje pruritis z ali brez eritrema) pri bolnikih, zdravljenih z eksenatidom v obliki s podaljšanim sproščanjem, je bila v 30-tedenski in dveh 26-tedenskih študijah 9 %.
English: Based on hypoglycaemic events that have symptoms consistent with hypoglycaemia with a concomitant glucose value of <54 mg/dl (3 mmol/l) prior to treatment.
Slovenian: Na podlagi hipoglikemij, ki imajo simptome, značilne za hipoglikemijo, ter jih ob tem spremlja koncentracija glukoze pred zdravljenjem < 54 mg/dl (3 mmol/l).
English: In a 28-week open-label study (oral medication-blinded), Bydureon BCise was compared to sitagliptin and placebo in subjects also using metformin ≥ 1,500 mg daily.
Slovenian: V odprti 28-tedenski študiji (slepljeni za peroralno zdravljenje) so zdravilo Bydureon BCise primerjali s sitagliptinom in placebom pri preiskovancih, ki so uporabljali tudi ≥ 1.500 mg metformina na dan.
English: If you use more of this medicine than you should, please consult your doctor first as you may need medical treatment.
Slovenian: Če ste uporabili večji odmerek zdravila Bydureon, kot bi smeli Če ste uporabili več tega zdravila, kot bi smeli, se o tem najprej posvetujte z zdravnikom, saj boste morda potrebovali zdravljenje.
English: Prior to use of the pen, it is recommended that you should be trained by a doctor or diabetes nurse on its proper use.
Slovenian: Priporočljivo je, da vas pred uporabo peresnika zdravnik ali medicinska sestra v diabetološki ambulanti nauči njegove pravilne uporabe.
English: Common questions and answers.
Slovenian: Pogosta vprašanja in odgovori.
English: When added to sulphonylurea therapy, a reduction in the dose of sulphonylurea should be considered to reduce the risk of hypoglycaemia (see section 4.4).
Slovenian: Kadar dodamo zdravljenju s sulfonilsečnino, moramo premisliti o zmanjšanju odmerka sulfonilsečnine, da zmanjšamo tveganje za pojav hipoglikemije (glejte poglavje 4.4).
English: This reduction in body weight was seen irrespective of the occurrence of nausea although the reduction was larger in the group with nausea (mean reduction of -1.9 kg to -5.2 kg with nausea versus -1.0 kg to -2.9 kg without nausea).
Slovenian: To znižanje telesne mase pri bolnikih je bilo neodvisno od pojava navzee, bilo pa je večje pri skupini z navzeo (povprečno znižanje -1,9 kg do -5,2 kg z navzeo proti -1,0 kg do -2,9 kg brez navzee).
English: Place the needle, vial connector package, vial, and syringe on a clean, flat surface.
Slovenian: Iglo, paket s povezovalcem viale, vialo in injekcijsko brizgo postavite na čisto, ravno površino.
English: Subcutaneous injection site nodules were observed frequently in clinical studies, consistent with the known properties of poly (D,L-lactide co-glycolide) polymer microsphere formulations.
Slovenian: V kliničnih študijah so se na mestu injiciranja pogosto pojavili podkožni noduli, kar je skladno z znanimi lastnostmi poli (D,L-laktid koglikolid) polimernih mikrosfernih formulacij.
English: There have been uncommon events of altered renal function with exenatide, including increased serum creatinine, renal impairment, worsened chronic renal failure and acute renal failure, sometimes requiring haemodialysis.
Slovenian: Z eksenatidom so bili zabeleženi občasni primeri spremenjenega delovanja ledvic, vključno z zvišanjem kreatinina v serumu, okvaro ledvic, poslabšanjem kronične odpovedi ledvic in akutno odpovedjo ledvic, z občasno potrebo po hemodializi.
English: In postmarketing experiences, cases with injection site abscesses and cellulitis have been reported.
Slovenian: V obdobju trženja zdravila so poročali o abscesih in celulitisu na mestu injiciranja.
English: • WITHOUT twisting the knob, ROTATE the pen every few taps.
Slovenian: • Peresnik vsakih nekaj udarcev OBRNITE, NE DA BI pri tem zasukali gumb.
English: Clinical studies with prolonged-release exenatide formulations have indicated improved beta-cell function, using measures such as the homeostasis model assessments (HOMA-B).
Slovenian: Klinične študije z eksenatidom v obliki s podaljšanim sproščanjem so pokazale izboljšano delovanje beta celic, kar je bilo dokazano z metodami kot je ocenjevanje homeostaznega modela (HOMA-B).
English: The improvement in fasting plasma glucose concentrations was durable through 52 weeks.
Slovenian: Izboljšanje v koncentraciji glukoze v plazmi na tešče je trajalo vseh 52 tednov.
English: DO NOT try to recap or reuse the needle.
Slovenian: NE POSKUŠAJTE ponovno namestiti pokrovčka na iglo ali igle uporabiti znova.
English: After discontinuation, the effect of prolonged-release exenatide may continue as plasma levels of exenatide decline over 10 weeks.
Slovenian: Po ukinitvi zdravljenja se lahko učinek eksenatida v obliki s podaljšanim sproščanjem nadaljuje, saj koncentracija eksenatida v plazmi pada naslednjih 10 tednov.
English: The powder is white to off-white and the solvent is a clear, colourless to pale yellow to pale brown solution.
Slovenian: Prašek je bel do belkast in vehikel je bistra, brezbarvna do bledo rumena oziroma do bledo rjava raztopina.
English: Patients on pioglitazone gained weight (Table 6).
Slovenian: Bolniki na pioglitazonu so pridobili na telesni masi (Preglednica 6).
English: The medicine is injected into your skin (subcutaneously).
Slovenian: Zdravilo se injicira pod kožo (subkutano).
English: The solvent should only be used if it is clear and free of particulate matter.
Slovenian: Vehikel se lahko uporabi le v primeru, ko je bister in ne vsebuje delcev.
English: - The other ingredients are: - In the powder: poly (D,L-lactide-co-glycolide) and sucrose.
Slovenian: - Druge sestavine zdravila so: - V prašku: poli (D,L-laktid koglikolid) in saharoza.
English: The pen must be removed from the refrigerator for at least 15 minutes prior to injection.
Slovenian: Peresnik je treba vsaj 15 minut pred injiciranjem vzeti iz hladilnika.
English: Increased heart rate
Slovenian: Zvišan srčni utrip
English: INSTRUCTIONS FOR THE USER Read these instructions carefully before use
Slovenian: Pred uporabo natančno preberite ta navodila
English: Following weekly administration of 2 mg prolonged-release exenatide, mean exenatide concentrations exceeded minimal efficacious concentrations (~ 50 pg/ml) in 2 weeks with gradual increase in the average plasma exenatide concentration over 6 to 7 weeks.
Slovenian: Ob tedenskem dajanju 2 mg eksenatida v obliki s podaljšanim sproščanjem je povprečna koncentracija eksenatida v dveh tednih presegla minimalno učinkovito koncentracijo (~ 50 pg/ml), s postopnim povečevanjem povprečne plazemske koncentracije eksenatida preko 6 do 7 tednov.
English: Follow the “Instructions for the User” provided in the carton to inject Bydureon
Slovenian: Sledite “Navodilom za uporabnika”, ki se nahajajo v škatli, za injiciranje zdravila Bydureon.
English: Needle Top of pen
Slovenian: Igla Vrh peresnika
English: Rate based on twelve prolonged-release exenatide completed long-term efficacy and safety studies n=2868 total (patients on sulphonylurea n=1002).
Slovenian: Pogostnost na podlagi dvanajstih dokončanih dolgoročnih študij učinkovitosti in varnosti eksenatida v obliki s podaljšanim sproščanjem, n skupaj = 2868, (število bolnikov na sulfonilsečnini n = 1002).
English: With your thumb, push down the plunger until it stops and hold your thumb in place.
Slovenian: S palcem pritisnite bat navzdol, dokler se ne ustavi in palec držite na mestu.
English: The need for additional antihyperglycaemic medication was reduced by 33% % with the prolongedrelease exenatide group (exposure-adjusted incidence of 10.5 per 100 pt-year) compared to the placebo group (exposure-adjusted incidence of 15.7 per 100 pt-year).
Slovenian: Potreba po dodatnem antihiperglikemičnem zdravilu se je v skupini z eksenatidom v obliki s podaljšanim sproščanjem zmanjšala za 33 % (za izpostavljenost korigirana pojavnost 10,5 na 100 bolnikov-let) v primerjavi s placebom (za izpostavljenost korigirana pojavnost 15,7 na 100 bolnikov-let).
English: You should inject this medicine into the skin (subcutaneous injection) of your stomach area (abdomen), upper leg (thigh), or the back of your upper arm. Do not inject into a vein or muscle.
Slovenian: To zdravilo si injicirajte v kožo (subkutana injekcija) področja trebuha (abdomna), zgornjega dela noge (stegno) ali zadnjega dela nadlakti.
English: Remove the syringe.
Slovenian: Odstranite injekcijsko brizgo.
English: A. Let your pen come to room temperature.
Slovenian: A. Pustite, da se peresnik ogreje na sobno temperaturo.
English: If you see white medicine on the sides, bottom or top of the pen window, the medicine is NOT mixed well.
Slovenian: Če vidite belo zdravilo ob straneh, na dnu ali na vrhu okenca peresnika, zdravilo NI dobro premešano.
English: If a different glucose-lowering treatment is started after the discontinuation of prolonged-release exenatide, consideration should be given to the prolonged release of the product (see section 5.2).
Slovenian: Če se po končanem zdravljenju z eksenatidom v obliki s podaljšanim sproščanjem začne zdravljenje z drugim antidiabetikom, je potrebno upoštevati podaljšan učinek tega zdravila (glejte poglavje 5.2).
English: Most episodes of nausea were mild to moderate, associated with the initiation of treatment and decreased over time.
Slovenian: Večinoma je bila navzea blaga do zmerna, povezana z uvedbo zdravila ter se je sčasoma zmanjšala.
English: Do not remove the needle cover yet.
Slovenian: Pokrova igle za zdaj še ne odstranite.
English: Each dose should be administered in the abdomen, thigh, or the back of the upper arm as a subcutaneous injection immediately after the medicinal product is fully mixed.
Slovenian: Vsak odmerek moramo kot subkutano injekcijo dati v trebuh, stegno ali nadlaket takoj, ko je zdravilo popolnoma premešano.
English: In the 4 comparator-controlled studies, this reduction in body weight was seen in patients treated with prolonged-release exenatide irrespective of the occurrence of nausea although the reduction was larger in the group with nausea (mean reduction of -2.9 kg to -5.2 kg with nausea versus -2.2 kg to -2.9 kg without nausea).
Slovenian: V 4 s primerjalnimi zdravili kontroliranih študijah je bilo to znižanje telesne mase pri bolnikih, ki so se zdravili z eksenatidom v obliki s podaljšanim sproščanjem, neodvisno od pojava navzee, bilo pa je večje pri skupini z navzeo (povprečno znižanje -2,9 kg do -5,2 kg z navzeo proti -2,2 kg do -2,9 kg brez navzee).
English: Clinical experience in patients with moderate renal impairment (creatinine clearance 30 to 50 ml/min) is limited (see section 5.2).
Slovenian: Kliničnih izkušenj pri bolnikih z zmerno okvaro ledvic (očistek kreatinina 30 do 50 ml/min) je malo (glejte poglavje 5.2).
English: The reductions in body weight were sustained at Week 52.
Slovenian: Zmanjšanje telesne mase je bilo po 52 tednih ohranjeno.
English: Do not throw the container in your household waste.
Slovenian: Vsebnika ne odvrzite med gospodinjske odpadke.
English: Use your thumb to remove the green cap.
Slovenian: S palcem odstranite zelen pokrovček.
English: Vial connector
Slovenian: viala povezovalec viale (vial connector)
English: In two studies prolonged-release exenatide 2 mg once weekly has been compared to immediate-release exenatide 5 mcg given twice daily for 4 weeks followed by immediate-release exenatide 10 mcg given twice daily.
Slovenian: Dve študiji z eksenatidom v obliki s podaljšanim sproščanjem 2 mg enkrat tedensko sta bili primerjani z eksenatidom v obliki s takojšnim sproščanjem 5 µg dvakrat dnevno 4 tedne, čemur je sledil eksenatid v obliki s takojšnim sproščanjem 10 µg dvakrat dnevno.
English: • Read the Package Leaflet carefully.
Slovenian: • Natančno preberite navodilo za uporabo.
English: With the other hand, twist the orange connector to remove.
Slovenian: Z drugo roko odvijte oranžni povezovalec in ga odstranite.
English: Now, hold the vial so the syringe is pointing up.
Slovenian: Sedaj primite vialo tako, da injekcijska brizga gleda gor.
English: Population pharmacokinetic analysis of renal impaired patients receiving 2 mg prolonged-release exenatide indicate that there may be an increase in systemic exposure of approximately 74% and 23% (median prediction in each group) in moderate (N = 10) and mild (N = 56) renal impaired patients, respectively as compared to normal (N = 84) renal function patients.
Slovenian: Populacijska farmakokinetična analiza bolnikov z okvaro ledvic, ki so prejemali 2 mg eksenatida v obliki s podaljšanim sproščanjem, kaže, da lahko pride do zvišane sistemske izpostavljenosti pri približno 74 % in 23 % (predvideni srednji vrednosti v vsaki skupini) bolnikih z zmerno (n = 10) in blago (n = 56) okvaro ledvic, v primerjavi z bolniki z normalnim (n = 84) delovanjem ledvic.
English: Use a new injection needle for each injection and dispose of it safely after each use as instructed by your doctor or diabetes nurse.
Slovenian: Za vsako injiciranje uporabite novo injekcijsko iglo in jo po vsaki uporabi varno zavrzite, kot vam je naročil zdravnik ali medicinska sestra v diabetološki ambulanti.
English: The results of two studies with Bydureon BCise and six long-term clinical studies of prolonged-release exenatide are presented below; these studies comprised 1766 subjects (556 treated with Bydureon BCise), 53% men and 47% women, 304 subjects (17%) were ≥ 65 years of age.
Slovenian: Te študije so vključevale 1766 preiskovancev (556 zdravljenih z zdravilom Bydureon BCise), 53 % moških in 47 % žensk; 304 osebe (17 %) so bile stare ≥ 65 let.
English: Furthermore, in the clinical studies, patients on a sulphonylurea combination with mild renal impairment had an increased incidence of hypoglycaemia compared to patients with normal renal function.
Slovenian: V kliničnih študijah pri bolnikih z blago okvaro ledvic, ki so jemali kombinacijo s sulfonilsečnino, je bila incidenca hipoglikemije večja v primerjavi z bolniki z normalnim delovanjem ledvic.
English: Prolonged-release exenatide 2 mg + Insulin glargine
Slovenian: 2 mg eksenatida v obliki s podaljšanim sproščanjem + insulin glargin
English: No pharmacokinetics study of prolonged-release exenatide has been conducted in the paediatric population.
Slovenian: Pri pediatrični populaciji niso izvedli nobenih farmakokinetičnih študij z eksenatidom v obliki s podaljšanim sproščanjem.
English: The suspension is packaged in a 2-ml Type I glass cartridge, sealed at one end with a (bromobutyl) rubber seal/cap combination (combiseal), and at the other end with a (bromobuty) rubber plunger.
Slovenian: Suspenzija je pakirana v 2-ml vložek iz stekla tipa I, ki je na eni strani zaprt s kombinacijo (brombutilne) gumijaste zapore/pokrovčka (kombinirana zapora) in na drugi strani z (brombutilnim) gumijastim batom.
English: The following interaction studies have been conducted using 10 mcg immediate-release exenatide but not prolonged-release exenatide formulations:
Slovenian: Sledeče študije medsebojnega delovanja so bile narejene za uporabo 10 μg eksenatida v obliki s takojšnim sproščanjem, in ne za uporabo eksenatida v obliki s podaljšanim sproščanjem: